We use cookies for a better user experience. Read our Privacy Policy

I Agree

Ultra-large Volume Wearable Injectors Market

Ultra-large Volume Wearable Injectors Market (Indication: Diabetes, Autoimmune Diseases, Oncology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Ultra-large Volume Wearable Injectors Market Outlook 2031

  • The global ultra-large volume wearable injectors market was valued at US$ 2.8 Bn in 2021
  • The global market is projected to grow at a CAGR of 9.1% from 2022 to 2031
  • The global ultra-large volume wearable injectors market is anticipated to exceed US$ 6.6 Bn by the end of 2031

Analysts’ Viewpoint on Ultra-Large Volume Wearable Injectors Market Scenario

The global ultra-large volume wearable injectors market is growing at a rapid pace, as there are a large number of patients who depend on large-volume wearable injectors to receive continuous drug delivery into their body. The surge in the demand for more advanced treatment options for chronic diseases, such as diabetes, boosts the ultra-large volume wearable injectors market. Additionally, there has been an increase in focus by key players on the launch of new products in the market; for instance, West Pharmaceutical announced the new extensions of its SmartDose drug delivery platform, including several new wearable injectors that enable patients to inject 10 mL volume in easy-to-use, wearable formats.

ultra large volume wearable injectors market

Overview of Ultra-Large Volume Wearable Injectors Market

Ultra-large volume wearable injectors are wearable injector systems that are able to store large volumes of drugs and designed to deliver the drug subcutaneously over an extended period of time. These wearable drug delivery devices are majorly used in the treatment of chronic diseases such as cancer, diabetes, and autoimmune disorders. Wearable injectors offer a solution to the challenge of delivering sub-cutaneous injections of increasing dosing volumes and viscosities in non-clinical settings. West Pharmaceutical Company’s SmartDose 10 On-Body Delivery System (OBDS) consists of a battery-powered, wearable on-body injector with a separate, pre-fillable, polymer-based cartridge that is filled with the drug product.

The ability of ultra-large volume wearable injectors to accommodate new formulations with higher volume and viscosity improves patient experience, and potentially increases adherence to therapies.

Request a sample to get extensive insights into the Ultra-large Volume Wearable Injectors Market

Increasing Prevalence of Chronic Diseases to Drive Global Market

Chronic diseases, such as diabetes, cardiovascular disorders, autoimmune disorders, and various types of cancer, are the leading causes of death and disability worldwide. According to the Centers for Disease Control and Prevention (CDC) in 2019, nearly six in 10 individuals suffer from, at least, one chronic disease in the U.S.

Cardiovascular diseases (CVDs) are a significant cause of mortality, globally, owing to the hectic lifestyle. As per the World Health Organization (WHO), CVDs are the number one cause of death, globally, taking an estimated 17.9 million lives each year. According to the International Diabetes Federation (IDF), around 537 million adults (aged 20 -79) are living with diabetes globally. Furthermore, it has been stated that the number of diabetic patients would increase to 643 million by 2030 and 783 million by the year 2045.

In diabetes patients, the exogenous insulin is usually administered through a subcutaneous route of administration for diabetes management. The wearable injector is an ideal drug delivery method for painless and accurate dosage of insulin.

Surge in Usage of Self Administration Devices to Boost Global Market

Self-administration devices are being increasingly used, as most of the people prefer treating themselves at the convenience of their home or own space. After the onset of the COVID-19 pandemic, most of the people preferred home treatment, as they did not want to contract the infection. Therefore, COVID-19 prompted the use of self-administration devices among people who required continuous drug delivery or treatment. Therefore, the wearable injectors market is estimated to grow due to the dependency of individuals on self-administration devices.

Request a custom report on Ultra-large Volume Wearable Injectors Market

Rise in Number of Insulin-dependent Diabetic Patients Needing Wearable Injectors to Propel Market

The diabetes segment accounted for a dominant share of the global market in 2021. The segment is anticipated to expand at a high CAGR from 2022 to 2031. The growth of the diabetes segment is due to a rise in the number of diabetic patients globally. Moreover, diabetic patients who are insulin dependent prefer wearing an injector on their body rather than using a syringe to inject themselves. Therefore, these factors are estimated to boost the ultra-large volume wearable injectors market.

For instance, as per the World Health Organization (WHO), around 422 million people have diabetes, worldwide; most of those people are living in low and middle income countries, and 1.5 million deaths are directly attributed to diabetes each year. Number of cases and the prevalence of diabetes have been rising at a steady pace for the past few decades.

Convenience of Purchase of Wearable Injectors from Retail Pharmacies and Drug Stores to Fuel Segment Growth

In terms of distribution channel, the global market has been divided into retail pharmacies & drug stores, e-commerce, and others. The high market share held by the retail pharmacies & drug stores segment is due to increased number of patients that are preferring ultra-large volume wearable injectors for various drug deliveries. Retail pharmacies and drug stores sell different wearable injectors and hence, this has become convenient for purchasing and usage.

Regional Outlook of Ultra-large Volume Wearable Injectors Market

North America dominated the global ultra large volume wearable injectors market. The growth of the market in the region can be attributed to an increase in prevalence of chronic diseases, such as cancer, diabetes, oncology, cardiovascular diseases; development of new products, and presence of key market players in the region. Furthermore, technological advancements in the treatment of diseases are expected to be a key driver for the ultra-large volume wearable injectors market in the U.S. and Canada.

Asia Pacific is the expected to be fastest growing market for ultra-large volume wearable injectors, owing to increase in geriatric population, rise in prevalence of chronic diseases, supportive government initiatives, and research in the field of wearable medical devices. Additionally, investments by international market players fuel the growth of the market.

Analysis of Key Players in Ultra-large Volume Wearable Injectors Market

Amgen, Inc., Medtronic, BD, Insulet Corporation, Gerresheimer AG (Sensile Medical), West Pharmaceutical Services, Inc., Ypsomed AG, Tandem Diabetes Care, Inc., Cequr SA, Debiotech S.A, Elcam Medical, and VALERITAS, INC. are among the key companies operating in the ultra-large volume wearable injectors market. This report profiles key players in the global ultra-large volume wearable injectors market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global ultra-large volume wearable injectors market is highly fragmented, with the presence of numerous global as well as regional players.

Key Developments in Ultra-large Volume Wearable Injectors Market

Leading players in the ultra-large volume wearable injectors market are engaged in regulatory approvals, launch of technologically advanced products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the global ultra-large volume wearable injectors market. Companies have increased their research and development activities for ultra-large volume wearable injectors.

  • In February 2020, Becton, Dickinson, and Company completed the 50-subject human clinical trial with the BD Libertas Wearable Injector
  • In July 2018, Sensile Medical, Sanofi, and Verily joined forces for the development and commercialization of the connected insulin patch pump. This partnership between three parties is focused on the development and commercialization of a new generation of “all-in-one” pre-filled insulin patch pump. It is primarily used in patients with type 2 diabetes.

Ultra-large Volume Wearable Injectors Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 2.8 Bn

Market Forecast Value in 2031

US$ 6.6 Bn

Growth Rate (CAGR)

9.1%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market Share Analysis by Company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Indication
    • Diabetes
    • Autoimmune Diseases
    • Oncology
    • Others
  • By Distribution Channel
    • Retail Pharmacies & Drug stores
    • E-commerce
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Becton, Dickinson and Company
  • Bühler Motor GmbH
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Medtronic
  • Sonceboz
  • Enable Injections
  • Subcuject Aps
  • Nemera
  • Eitan Medical 
  • Weibel CDS AG
  • Gerresheimer AG

Customization Scope

Available upon request

Pricing

Available upon request

Ultra-large Volume Wearable Injectors Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global ultra-large volume wearable injectors market in 2021?

The global ultra-large volume wearable injectors market was valued at US$ 2.8 Bn in 2021.

How big will be the ultra-large volume wearable injectors market in 2031?

The global ultra-large volume wearable injectors market is likely to surpass US$ 6.6 Bn by 2031.

What was the CAGR of global ultra-large volume wearable injectors market from 2017 to 2021?

The global ultra-large volume wearable injectors market is anticipated to record a CAGR of 7.8% from 2017 to 2021.

What will be the CAGR of global ultra-large volume wearable injectors market during the forecast period (2022-2031)?

The global ultra-large volume wearable injectors market is anticipated to record a CAGR of 9.1% from 2022 to 2031.

What are the prominent trends impacting the market growth?

Increasing prevalence of chronic diseases positively impacts the global market.

What is the market share of the leading segment in the global ultra-large volume wearable injectors market?

The diabetes segment held more than 60% share of the global ultra-large volume wearable injectors market in 2021.

Which region held a key market share during the forecast period?

North America is expected to hold a key share of the global market during the forecast period.

Who are the prominent players in the global ultra-large volume wearable injectors market?

Prominent players in the global ultra-large volume wearable injectors market include Becton, Dickinson and Company, Bühler Motor GmbH, West Pharmaceutical Services, Inc., Ypsomed AG, Medtronic, Sonceboz, Enable Injections, Subcuject Aps, Nemera, Eitan Medical, Weibel CDS AG, and Gerresheimer AG.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Ultra-large Volume Wearable Injectors Market

4. Market Overview

    4.1. Introduction

        4.1.1. Indication Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Industry Developments

    5.3. Ultra-large Volume Wearable Injectors Overview

    5.4. COVID-19 Pandemics Impact on Industry

6. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Indication

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Indication, 2017–2031

        6.3.1. Diabetes 

        6.3.2. Autoimmune Diseases

        6.3.3. Oncology

        6.3.4. Others

    6.4. Market Attractiveness, by Indication

7. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Distribution Channel

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Distribution Channel, 2017–2031

        7.3.1. Retail Pharmacies & Drug stores

        7.3.2. E-commerce

        7.3.3. Others

    7.4. Market Attractiveness, by Distribution Channel

8. Global Ultra-large Volume Wearable Injectors Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness, by Region

9. North America Ultra-large Volume Wearable Injectors Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Indication, 2017–2031

        9.2.1. Diabetes

        9.2.2. Autoimmune Diseases

        9.2.3. Oncology

        9.2.4. Others

    9.3. Market Value Forecast, by Distribution Channel, 2017–2031

        9.3.1. Retail Pharmacies & Drug stores

        9.3.2. E-commerce

        9.3.3. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Indication

        9.5.2. By Distribution Channel

        9.5.3. By Country

10. Europe Ultra-large Volume Wearable Injectors Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Indication, 2017–2031

        10.2.1. Diabetes

        10.2.2. Autoimmune Diseases

        10.2.3. Oncology

        10.2.4. Others

    10.3. Market Value Forecast, by Distribution Channel, 2017–2031

        10.3.1. Retail Pharmacies & Drug stores

        10.3.2. E-commerce

        10.3.3. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Indication

        10.5.2. By Distribution Channel

        10.5.3. By Country/Sub-region

11. Asia Pacific Ultra-large Volume Wearable Injectors Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Indication, 2017–2031

        11.2.1. Diabetes

        11.2.2. Autoimmune Diseases

        11.2.3. Oncology

        11.2.4. Others

    11.3. Market Value Forecast, by Distribution Channel, 2017–2031

        11.3.1. Retail Pharmacies & Drug stores

        11.3.2. E-commerce

        11.3.3. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Indication

        11.5.2. By Distribution Channel

        11.5.3. By Country/Sub-region

12. Latin America Ultra-large Volume Wearable Injectors Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Indication, 2017–2031

        12.2.1. Diabetes

        12.2.2. Autoimmune Diseases

        12.2.3. Oncology

        12.2.4. Others

    12.3. Market Value Forecast, by Distribution Channel, 2017–2031

        12.3.1. Retail Pharmacies & Drug stores

        12.3.2. E-commerce

        12.3.3. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Indication

        12.5.2. By Distribution Channel

        12.5.3. By Country/Sub-region

13. Middle East & Africa Ultra-large Volume Wearable Injectors Market Analysis and Forecast

. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Indication, 2017–2031

        13.2.1. Diabetes

        13.2.2. Autoimmune Diseases

        13.2.3. Oncology

        13.2.4. Others

    13.3. Market Value Forecast, by Distribution Channel, 2017–2031

        13.3.1. Retail Pharmacies & Drug stores

        13.3.2. E-commerce

        13.3.3. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Indication

        13.5.2. By Distribution Channel

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Company Profiles

        14.2.1. Becton, Dickinson and Company

            14.2.1.1. Company Overview

            14.2.1.2. Financial Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. SWOT Analysis

            14.2.1.5. Strategic Overview

        14.2.2. Bühler Motor GmbH

            14.2.2.1. Company Overview

            14.2.2.2. Financial Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. SWOT Analysis

            14.2.2.5. Strategic Overview

        14.2.3. West Pharmaceutical Services, Inc.

            14.2.3.1. Company Overview

            14.2.3.2. Financial Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. SWOT Analysis

            14.2.3.5. Strategic Overview

        14.2.4. Ypsomed AG

            14.2.4.1. Company Overview

            14.2.4.2. Financial Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. SWOT Analysis

            14.2.4.5. Strategic Overview

        14.2.5. Medtronic

            14.2.5.1. Company Overview

            14.2.5.2. Financial Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. SWOT Analysis

            14.2.5.5. Strategic Overview

        14.2.6. Sonceboz

            14.2.6.1. Company Overview

            14.2.6.2. Financial Overview

            14.2.6.3. Product Portfolio

            14.2.6.4. SWOT Analysis

            14.2.6.5. Strategic Overview

        14.2.7. Enable Injections

            14.2.7.1. Company Overview

            14.2.7.2. Financial Overview

            14.2.7.3. Product Portfolio

            14.2.7.4. SWOT Analysis

            14.2.7.5. Strategic Overview

        14.2.8. Subcuject Aps

            14.2.8.1. Company Overview

            14.2.8.2. Financial Overview

            14.2.8.3. Product Portfolio

            14.2.8.4. SWOT Analysis

            14.2.8.5. Strategic Overview

        14.2.9. Nemera

            14.2.9.1. Company Overview

            14.2.9.2. Financial Overview

            14.2.9.3. Product Portfolio

            14.2.9.4. SWOT Analysis

            14.2.9.5. Strategic Overview

        14.2.10. Eitan Medical

            14.2.10.1. Company Overview

            14.2.10.2. Financial Overview

            14.2.10.3. Product Portfolio

            14.2.10.4. SWOT Analysis

            14.2.10.5. Strategic Overview

        14.2.11. Weibel CDS AG

            14.2.11.1. Company Overview

            14.2.11.2. Financial Overview

            14.2.11.3. Product Portfolio

            14.2.11.4. SWOT Analysis

            14.2.11.5. Strategic Overview

        14.2.12. Gerresheimer AG

            14.2.12.1. Company Overview

            14.2.12.2. Financial Overview

            14.2.12.3. Product Portfolio

            14.2.12.4. SWOT Analysis

            14.2.12.5. Strategic Overview

List of Tables

Table 01: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 02: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017‒2031

Table 03: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Region, 2017–2031

Table 04: North America Continence Care Market Value (US$ Bn) Forecast, by Country, 2017–2031

Table 05: North America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 06: North America Ultra-large Volume Wearable Injectors Market (US$ Bn) Forecast, by Distribution Channel, 2017–2031

Table 07: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017–2031

Table 08: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 09: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

Table 10: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017–2031

Table 11: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 12: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

Table 13: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 15: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

Table 16: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Country/Sub-Region, 2017–2031

Table 17: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Indication, 2017–2031

Table 18: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017–2031

Figure 02: Global Ultra-large Volume Wearable Injectors Market Value Share, by Indication, 2021

Figure 03: Global Ultra-large Volume Wearable Injectors Market Value Share, by Distribution Channel, 2021

Figure 04: Global Ultra-large Volume Wearable Injectors Market Value Share, by Region, 2021

Figure 05: Global Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031

Figure 06: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2021–2031

Figure 07: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Diabetes, 2017–2031

Figure 08: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Autoimmune Diseases, 2017–2031

Figure 09: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Oncology, 2017–2031

Figure 10: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Others, 2017–2031

Figure 11: Global Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031

Figure 12: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 13: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Retail Pharmacies & Drug stores, 2017–2031

Figure 14: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by E-commerce, 2017–2031

Figure 15: Global Ultra-large Volume Wearable Injectors Market (US$ Bn), by Others, 2017–2031

Figure 16: Global Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Region, 2021 and 2031

Figure 17: Global Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Region, 2022–2031

Figure 18: North America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017–2031

Figure 19: North America Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country, 2021 and 2031

Figure 20: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country, 2022–2031 

Figure 21: North America Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031

Figure 22: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022–2031

Figure 23: North America Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031

Figure 24: North America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2021–2031

Figure 25: Europe Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017–2031

Figure 26: Europe Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

Figure 27: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 28: Europe Ultra-large Volume Wearable Injectors Market, by Indication, 2020 and 2031

Figure 29: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022–2031

Figure 30: Europe Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031

Figure 31: Europe Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 32: Asia Pacific Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017–2031

Figure 33: Asia Pacific Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

Figure 34: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 35: Asia Pacific Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031

Figure 36: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022–2031

Figure 37: Asia Pacific Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 38: Asia Pacific Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031

Figure 39: Latin America Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017–2031

Figure 40: Latin America Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

Figure 41: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 42: Latin America Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031

Figure 43: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022–2031

Figure 44: Latin America Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031

Figure 45: Latin America Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 46: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value (US$ Bn) Forecast, 2017–2031

Figure 47: Middle East & Africa Ultra-large Volume Wearable Injectors Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

Figure 48: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 49: Middle East & Africa Ultra-large Volume Wearable Injectors Market, by Indication, 2021 and 2031

Figure 50: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Indication, 2022–2031

Figure 51: Middle East & Africa Ultra-large Volume Wearable Injectors Market, by Distribution Channel, 2021 and 2031

Figure 52: Middle East & Africa Ultra-large Volume Wearable Injectors Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

344

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved